142 related articles for article (PubMed ID: 30348299)
1. HIF-1α drives cyst growth in advanced stages of autosomal dominant polycystic kidney disease.
Hofherr A; Busch T; Köttgen M
Kidney Int; 2018 Nov; 94(5):849-851. PubMed ID: 30348299
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease.
Kraus A; Peters DJM; Klanke B; Weidemann A; Willam C; Schley G; Kunzelmann K; Eckardt KU; Buchholz B
Kidney Int; 2018 Nov; 94(5):887-899. PubMed ID: 30173898
[TBL] [Abstract][Full Text] [Related]
3. Role of oxygen and the HIF-pathway in polycystic kidney disease.
Buchholz B; Eckardt KU
Cell Signal; 2020 May; 69():109524. PubMed ID: 31904413
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.
Buchholz B; Schley G; Faria D; Kroening S; Willam C; Schreiber R; Klanke B; Burzlaff N; Jantsch J; Kunzelmann K; Eckardt KU
J Am Soc Nephrol; 2014 Mar; 25(3):465-74. PubMed ID: 24203996
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD).
Belibi F; Zafar I; Ravichandran K; Segvic AB; Jani A; Ljubanovic DG; Edelstein CL
Am J Physiol Renal Physiol; 2011 May; 300(5):F1235-43. PubMed ID: 21270095
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
Safi W; Kraus A; Grampp S; Schödel J; Buchholz B
J Mol Med (Berl); 2020 Nov; 98(11):1547-1559. PubMed ID: 32885302
[TBL] [Abstract][Full Text] [Related]
7. P2Y2R is a direct target of HIF-1α and mediates secretion-dependent cyst growth of renal cyst-forming epithelial cells.
Kraus A; Grampp S; Goppelt-Struebe M; Schreiber R; Kunzelmann K; Peters DJ; Leipziger J; Schley G; Schödel J; Eckardt KU; Buchholz B
Purinergic Signal; 2016 Dec; 12(4):687-695. PubMed ID: 27565965
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-Inducible Factor 1α (HIF-1α), Angiopoietin-2 (ANG-2) and Endocan: Novel Biomarkers of Disease Progression Involving Polycystic Kidney Disease.
Rahbari-Oskoui FF; Chapman AB
Am J Nephrol; 2018; 47(4):228-230. PubMed ID: 29597208
[No Abstract] [Full Text] [Related]
9. Involvement of hypoxia-inducible transcription factors in polycystic kidney disease.
Bernhardt WM; Wiesener MS; Weidemann A; Schmitt R; Weichert W; Lechler P; Campean V; Ong AC; Willam C; Gretz N; Eckardt KU
Am J Pathol; 2007 Mar; 170(3):830-42. PubMed ID: 17322369
[TBL] [Abstract][Full Text] [Related]
10. Systemic Succinate, Hypoxia-Inducible Factor-1 Alpha, and IL-1β Gene Expression in Autosomal Dominant Polycystic Kidney Disease with and without Hypertension.
Kocyigit I; Taheri S; Eroglu E; Sener EF; Zararsız G; Uzun I; Tufan E; Mehmetbeyoglu E; Korkmaz Bayramov K; Sipahioglu MH; Ozkul Y; Tokgoz B; Oymak O; Axelsson J
Cardiorenal Med; 2019; 9(6):370-381. PubMed ID: 31319406
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study on hypoxia in spontaneous polycystic liver and kidney disease in rats.
Yoshida T; Kuwahara M; Maita K; Harada T
Exp Toxicol Pathol; 2001 Jun; 53(2-3):123-8. PubMed ID: 11484829
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with tempol does not significantly ameliorate renal tissue hypoxia or disease progression in a rodent model of polycystic kidney disease.
Ding A; Kalaignanasundaram P; Ricardo SD; Abdelkader A; Witting PK; Broughton BR; Kim HB; Wyse BF; Phillips JK; Evans RG
Clin Exp Pharmacol Physiol; 2012 Nov; 39(11):917-29. PubMed ID: 23006058
[TBL] [Abstract][Full Text] [Related]
13. The expression of somatostatin receptor 2 decreases during cyst growth in mice with polycystic kidney disease.
Lin C; Happé H; Veraar K; Scharpfenecker M; Peters DJ;
Exp Biol Med (Maywood); 2018 Sep; 243(13):1092-1098. PubMed ID: 30261745
[TBL] [Abstract][Full Text] [Related]
14. Anti-VEGF antibody treatment accelerates polycystic kidney disease.
Raina S; Honer M; Krämer SD; Liu Y; Wang X; Segerer S; Wüthrich RP; Serra AL
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F773-83. PubMed ID: 21677148
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
Liu C; Zhang Y; Yuan L; Fu L; Mei C
Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
[TBL] [Abstract][Full Text] [Related]
16. Altered Hippo signalling in polycystic kidney disease.
Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
[TBL] [Abstract][Full Text] [Related]
17. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-Inducible Factor-1α Activates the Transforming Growth Factor-β/SMAD3 Pathway in Kidney Tubular Epithelial Cells.
Kushida N; Nomura S; Mimura I; Fujita T; Yamamoto S; Nangaku M; Aburatani H
Am J Nephrol; 2016; 44(4):276-285. PubMed ID: 27607351
[TBL] [Abstract][Full Text] [Related]
19. Distribution of alpha-integrin subunits in fetal polycystic kidney diseases.
Daïkha-Dahmane F; Narcy F; Dommergues M; Lacoste M; Beziau A; Gubler MC
Pediatr Nephrol; 1997 Jun; 11(3):267-73. PubMed ID: 9203171
[TBL] [Abstract][Full Text] [Related]
20. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
Konda R; Sugimura J; Sohma F; Katagiri T; Nakamura Y; Fujioka T
J Urol; 2008 Aug; 180(2):481-5. PubMed ID: 18550099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
